US Patent Issued to Wyvern Pharmaceuticals on Jan. 20 for "Composition for regulating production of interfering ribonucleic acid" (Canadian Inventor)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,059, issued on Jan. 20, was assigned to Wyvern Pharmaceuticals Inc. (Calgary, Canada).

"Composition for regulating production of interfering ribonucleic acid" was invented by Bradley G. Thompson (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The embodiments of the present disclosure relate to decreasing the bioavailability of one or more target biomolecules by providing a composition that comprises a recombinant plasmid (RP) and one or more sequences of micro-interfering ribonucleic acid (miRNA). When the RP interacts with a target cell, it causes the target cell to upregulate production of the miRNA, which then decreases the bioava...